(NASDAQ: KALA) Kala Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 23.87%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.25%.
Kala Bio's earnings in 2025 is -$35,651,000.On average, 3 Wall Street analysts forecast KALA's earnings for 2025 to be -$34,348,050, with the lowest KALA earnings forecast at -$38,456,292, and the highest KALA earnings forecast at -$31,036,034.
In 2026, KALA is forecast to generate -$21,583,271 in earnings, with the lowest earnings forecast at -$25,164,352 and the highest earnings forecast at -$18,002,190.